Bill > HB1489

This bill requires the Maryland Medical Assistance Program to provide comprehensive coverage for obesity treatment starting July 1, 2026. The bill defines "comprehensive coverage for the treatment of obesity" as including intensive behavioral therapy, bariatric surgery, and FDA-approved anti-obesity medications, which are defined as medications approved by the Federal Food and Drug Administration for chronic weight management in patients with obesity. The coverage criteria for anti-obesity medications cannot be more restrictive than the FDA-approved indications for treatment. The Maryland Department of Health may use standard utilization management processes to determine medical necessity, similar to how they assess treatments for other medical conditions. The bill also mandates that the Department provide notice to program recipients about this new coverage by June 1, 2026, ensuring that recipients are informed about the expanded benefits before they take effect. This legislation aims to improve access to obesity treatment for Maryland Medical Assistance Program participants by providing a comprehensive approach to addressing obesity as a medical condition.

Government Affairs, Health and Social Services

https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB1489?ys=2025RS